References
- American Medical Association. (2021). Issue brief: Reports of increases in opioid- and other drug-related overdose and other concerns during COVID pandemic.
- Bird, S. M., McAuley, A., Perry, S., & Hunter, C. (2016). Effectiveness of Scotland’s National Naloxone Programme for reducing opioid-related deaths: a before (2006-10) versus after (2011-13) comparison. Addiction (Abingdon, England), 111(5), 883–891. https://doi.org/https://doi.org/10.1111/add.13265
- Bogan, C., Jennings, L., Haynes, L., Barth, K., Moreland, A., Oros, M., Goldsby, S., Lane, S., Funcell, C., & Brady, K. (2020). Implementation of emergency department–initiated buprenorphine for opioid use disorder in a rural southern state. Journal of Substance Abuse Treatment, 112, 73–78. https://doi.org/https://doi.org/10.1016/j.jsat.2020.02.007
- Burgess, L., Kynoch, K., & Hines, S. (2019). Implementing best practice into the emergency department triage process. International Journal of Evidence-Based Healthcare, 17(1), 27–35. https://doi.org/https://doi.org/10.1097/XEB.0000000000000144
- Cao, S. S., Dunham, S. I., & Simpson, S. A. (2020). Prescribing buprenorphine for opioid use disorders in the ED: A review of best practices, barriers, and future directions. Open Access Emergency Medicine: OAEM, 12, 261–274. https://doi.org/https://doi.org/10.2147/OAEM.S267416
- Glober, N., Mohler, G., Huynh, P., Arkins, T., O’Donnell, D., Carter, J., & Ray, B. (2020). Impact of COVID-19 pandemic on drug overdoses in Indianapolis. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 97(6), 802–807. https://doi.org/https://doi.org/10.1007/s11524-020-00484-0
- Harris, M., Johnson, S., Mackin, S., Saitz, R., Walley, A. Y., & Taylor, J. L. (2020). Low barrier Tele-Buprenorphine in the time of COVID-19: A case report. Journal of Addiction Medicine., 14(4), 136–138. https://doi.org/https://doi.org/10.1097/ADM.0000000000000682
- Jansma, B., Vakkalanka, P., Talan, D. A., Negaard, B., & Faine, B. A. (2020). Guideline adherence for the management of emergency department patients with febrile neutropenia and no infection source: Is there room for improvement? Journal of Oncology Pharmacy Practice: Official Publication of the International Society of Oncology Pharmacy Practitioners, 26(6), 1382–1389. https://doi.org/https://doi.org/10.1177/1078155219896396
- Kawasaki, S., Francis, E., Mills, S., Buchberger, G., Hogentogler, R., & Kraschnewski, J. (2019). Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania. Journal of Substance Abuse Treatment, 106, 58–64. https://doi.org/https://doi.org/10.1016/j.jsat.2019.08.016
- Lai, J. T., Goldfine, C. E., Chapman, B. P., Taylor, M. M., Rosen, R. K., Carreiro, S. P., & Babu, K. M. (2021). Nobody wants to be Narcan’d: A pilot qualitative analysis of drug users’ perspectives on naloxone. The Western Journal of Emergency Medicine, 22(2), 339–345. https://doi.org/https://doi.org/10.5811/westjem.2020.10.48768
- Langabeer, J. R., Champagne‐Langabeer, T., Yatsco, A. J., O’Neal, M. M., Cardenas‐Turanzas, M., Prater, S., Luber, S., Stotts, A., Fadial, T., Khraish, G., Wang, H., Bobrow, B. J., & Chambers, K. A. (2021). Feasibility and outcomes from an integrated bridge treatment program for opioid use disorder. Journal of the American College of Emergency Physicians Open, 2(2), 1–6. https://doi.org/https://doi.org/10.1002/emp2.12417[Mismatch
- Langabeer, J. R., Stotts, A. L., Bobrow, B. J., Wang, H. E., Chambers, K. A., Yatsco, A. J., Cardenas-Turanzas, M., & Champagne-Langabeer, T. (2021). Prevalence and charges of opioid-related visits to U.S. emergency departments. Drug Alcohol and Dependence, 221, 108568. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2021.108568
- Martin, A., Butler, K., Chavez, T., Herring, A., Wakeman, S., Hayes, B., & Raja, A. (2020). Beyond buprenorphine: Models of follow-up care for opioid use disorder in the Emergency Department. Western Journal of Emergency Medicine, 21(6), 257–263. https://doi.org/https://doi.org/10.5811/westjem.2020.7.46079
- McArdle, M. (2018). Opinion: The ‘moral hazard’ of naloxone in the opioid crisis. The Washington Post. https://www.washingtonpost.com/opinions/the-moral-hazard-of-naloxone-in-the-opioid-crisis/2018/03/08/c3584f16-2259-11e8-86f6-54bfff693d2b_story.html
- McGuire, A. B., Powell, K. G., Treitler, P. C., Wagner, K. D., Smith, K. P., Cooperman, N., Robinson, L., Carter, J., Ray, B., & Watson, D. P. (2020). Emergency department-based peer support for opioid use disorder: Emergent functions and forms. Journal of Substance Abuse Treatment, 108, 82–87. https://doi.org/https://doi.org/10.1016/j.jsat.2019.06.013
- Naumann, R. B., Durrance, C. P., Ranapurwala, S. I., Austin, A. E., Proescholdbell, S., Childs, R., Marshall, S. W., Kansagra, S., & Shanahan, M. E. (2019). Impact of a community-based naloxone distribution program on opioid overdose death rates. Drug Alcohol and Dependence, 204, 107536. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2019.06.038
- O’Donoghue, A. L., Biswas, N., Dechen, T., Anderson, T. S., Talmor, N., Punnamaraju, A., & Stevens, J. P. (2021). Trends in filled naloxone prescriptions before and during the COVID-19 pandemic in the United States. JAMA Health Forum, 2(5), e210393. https://doi.org/https://doi.org/10.1001/jamahealthforum.2021.0393
- Ochalek, T. A., Cumpston, K. L., Wills, B. K., Gal, T. S., & Moeller, F. G. (2020). Nonfatal opioid overdoses at an Urban Emergency Department during the COVID-19 pandemic. JAMA, 324(16), 1673–1674. https://doi.org/https://doi.org/10.1001/jama.2020.17477
- Samuels, E. A., Baird, J., Yang, E. S., & Mello, M. J. (2018). Adoption and utilization of an emergency department naloxone distribution and peer recovery coach consultation program. Academic Emergency Medicine, 26, 160–173. https://doi.org/https://doi.org/10.1111/acem.13545
- Samuels, E. A., Bernstein, S. L., Marshall, B. D. L., Krieger, M., Baird, J., & Mello, M. J. (2018). Peer navigation and take-home naloxone for opioid overdose emergency department patients: Preliminary patient outcomes. Journal of Substance Abuse Treatment, 94, 29–34. https://doi.org/https://doi.org/10.1016/j.jsat.2018.07.013
- Samuels, E. A., Mcdonald, J. V., Mccormick, M., Koziol, J., Friedman, C., & Alexander-Scott, N. (2019). Emergency Department and hospital care for opioid use disorder: implementation of statewide standards in Rhode Island, 2017-2018. American Journal of Public Health, 109(2), 263–266. https://doi.org/https://doi.org/10.2105/AJPH.2018.304847
- Schoolman-Anderson, K., Lane, R. D., Schunk, J. E., Mecham, N., Thomas, R., & Adelgais, K. (2018). Pediatric emergency department triage-based pain guideline utilizing intranasal fentanyl: Effect of implementation. The American Journal of Emergency Medicine, 36(9), 1603–1607. https://doi.org/https://doi.org/10.1016/j.ajem.2018.01.042
- Slavova, S., Rock, P., Bush, H. M., Quesinberry, D., & Walsh, S. L. (2020). Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug and Alcohol Dependence, 214, 108176. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2020.108176
- Vavilala, M. S., King, M. A., Yang, J.-T., Erickson, S. L., Mills, B., Grant, R. M., Blayney, C., Qiu, Q., Chesnut, R. M., Jaffe, K. M., Weiner, B. J., & Johnston, B. D. (2019). The Pediatric Guideline Adherence and Outcomes (PEGASUS) programme in severe traumatic brain injury: A single-centre hybrid implementation and effectiveness study. The Lancet Child & Adolescent Health, 3(1), 23–34. https://doi.org/https://doi.org/10.1016/S2352-4642(18)30341-9
- Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ (Clinical Research ed.), 346, f174 https://doi.org/https://doi.org/10.1136/bmj.f174
- Welch, A. E., Jeffers, A., Allen, B., Paone, D., & Kunins, H. V. (2019). Relay: A peer-delivered emergency department-based response to nonfatal opioid overdose. American Journal of Public Health, 109(10), 1392–1395. https://doi.org/https://doi.org/10.2105/AJPH.2019.305202
- Wenzel, K., & Fishman, M. (2021). Mobile van delivery of extended-release buprenorphine and extended-release naltrexone for youth with OUD: An adaptation to the COVID-19 emergency. Journal of Substance Abuse Treatment, 120, 108149. https://doi.org/https://doi.org/10.1016/j.jsat.2020.108149